These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26801080)

  • 21. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
    Wei C; Ni W; Cai X; Cui J
    Infect Dis (Lond); 2015; 47(12):846-51. PubMed ID: 26167850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
    Çıkman A; Parlak M; Bayram Y; Güdücüoğlu H; Berktaş M
    Afr Health Sci; 2016 Mar; 16(1):149-52. PubMed ID: 27358626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model.
    Lasko MJ; Tabor-Rennie JL; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2022 Oct; 77(11):3187-3193. PubMed ID: 36101486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stenotrophomonas maltophilia keratitis treated with trimethoprim-sulfamethoxazole.
    Díez-Álvarez L; Lumbreras-Fernández B; García-Pérez JL
    Arch Soc Esp Oftalmol; 2015 Nov; 90(11):539-41. PubMed ID: 26008926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem.
    Al-Jasser AM
    Ann Clin Microbiol Antimicrob; 2006 Sep; 5():23. PubMed ID: 16978420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
    Chung HS; Hong SG; Kim YR; Shin KS; Whang DH; Ahn JY; Park YJ; Uh Y; Chang CL; Shin JH; Lee HS; Lee K; Chong Y
    J Korean Med Sci; 2013 Jan; 28(1):62-6. PubMed ID: 23341713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
    Herrera-Heredia SA; Pezina-Cantú C; Garza-González E; Bocanegra-Ibarias P; Mendoza-Olazarán S; Morfín-Otero R; Camacho-Ortiz A; Villarreal-Treviño L; Rodríguez-Noriega E; Paláu-Davila L; Maldonado-Garza HJ; Flores-Treviño S
    J Med Microbiol; 2017 Aug; 66(8):1102-1109. PubMed ID: 28771141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
    Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole.
    Yilmaz M; Celik AF; Mert A
    J Infect Chemother; 2007 Apr; 13(2):122-3. PubMed ID: 17458682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan.
    Hase R; Sakurai A; Suzuki M; Itoh N; Hayakawa K; Uemura K; Matsumura Y; Kato H; Ishihara T; van Duin D; Ohmagari N; Doi Y; Saito S
    J Antimicrob Chemother; 2024 Aug; 79(8):1843-1855. PubMed ID: 38842502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.
    Juhász E; Krizsán G; Lengyel G; Grósz G; Pongrácz J; Kristóf K
    Ann Clin Microbiol Antimicrob; 2014 Dec; 13():333. PubMed ID: 25551459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
    Juhász E; Pongrácz J; Iván M; Kristóf K
    Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections.
    Farrell DJ; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2735-7. PubMed ID: 20368399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stenotrophomonas maltophilia: An emerging opportunistic nosocomial pathogen in a tertiary care hospital in Al Batinah North Governorate, Oman.
    Sannathimmappa MB; Nambiar V; Aravindakshan R; Al-Kasaby NM
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e66-e71. PubMed ID: 33777425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates.
    Karamanlıoğlu D; Dizbay M
    Turk J Med Sci; 2019 Apr; 49(2):683-686. PubMed ID: 30866602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergy of colistin with rifampin and trimethoprim/sulfamethoxazole on multidrug-resistant Stenotrophomonas maltophilia.
    Giamarellos-Bourboulis EJ; Karnesis L; Giamarellou H
    Diagn Microbiol Infect Dis; 2002 Nov; 44(3):259-63. PubMed ID: 12493173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
    Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
    J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review.
    Falagas ME; Valkimadi PE; Huang YT; Matthaiou DK; Hsueh PR
    J Antimicrob Chemother; 2008 Nov; 62(5):889-94. PubMed ID: 18662945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals.
    Tsiodras S; Pittet D; Carmeli Y; Eliopoulos G; Boucher H; Harbarth S
    Scand J Infect Dis; 2000; 32(6):651-6. PubMed ID: 11200376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
    Gallo SW; Figueiredo TP; Bessa MC; Pagnussatti VE; Ferreira CA; Oliveira SD
    Microb Drug Resist; 2016 Dec; 22(8):688-695. PubMed ID: 27007167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.